Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience

Lignende værker

• Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
  af: Ulrike Heinicke, et al.
  Udgivet: (2020-07-01)
• Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells
  af: Andreas von Knethen, et al.
  Udgivet: (2020-03-01)
• Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells
  af: von Knethen, Andreas, et al.
  Udgivet: (2020)
• Angiotensin II Brings More Questions Than Answers
  af: Farina, Nicholas, et al.
  Udgivet: (2018)
• Nrf2—A Molecular Target for Sepsis Patients in Critical Care
  af: Gunne, Sandra, et al.
  Udgivet: (2020)